NEW YORK----Synergy Pharmaceuticals, Inc. , a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that it has completed a private placement in which it raised gross proceeds of an aggregate $8.6 million through the sale of shares of common stock at a price of $0.70 per share.View the full article